What’s delaying the move toward Biopharma 4.0?


We have all heard the urgent prophecy of Biopharma 4.0 – several times by now.

We have patiently listened to the grand vision of smart processes that continuously learn from data, optimize conditions and predict the future, all in a couple of seconds. A promise of a coming enterprise-wide network that promotes communication and strategic insight, while controlling manufacturing, logistics and supply chains – for shorter time-to-market at lower cost. According to research by McKinsey1, the biopharmaceutical industry could achieve a whopping 40% gain in productivity2 by this imminent paradigm shift.

So, what’s the hold up? Download our eBook to find out more…

Download now

Request a DemoConnect with an Expert

More eBooks

Vaccines in the digital age

eBook CDMOs, don’t miss the train    https://www.idbs.com/learn-more/cdmos/ Navigating the 2020 market    Speed, safety and strict regulatory compliance in vaccine production are essential. However, ensuring both data quality…